Back
Bloomin Brands Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
57
BLMN
Bloomin Brands
Last Price:
14.24
Seasonality Move:
11.59%
Buy
60
SRPT
Sarepta Therapeutics
Last Price:
138.01
Seasonality Move:
14.88%
Buy
57
Bloomin Brands (BLMN)
is a Buy
Is Bloomin Brands a Buy, Sell or Hold?
- The current Bloomin Brands [BLMN] share price is $14.25. The Score for BLMN is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- BLMN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
60
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BLMN Stock Price Chart
What is Bloomin Brands's stock price today?
-
The Bloomin Brands share price today is $14.25
The current trend is relatively stagnant and BLMN is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $137.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
BLMN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.66 | Sell |
Relative Strength Index (14 RSI): | 47.97 | Sell |
Chaikin Money Flow: | 551097 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.16 - 16.32) | Sell |
Bollinger Bands (100): | (14.86 - 18.46) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 69.97 | Buy |
Chaikin Money Flow: | 2429824 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.85 - 129.69) | Buy |
Bollinger Bands (100): | (119.21 - 142.01) | Buy |
BLMN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.24 | Buy |
20-day SMA: | 14.31 | Sell |
50-day SMA: | 15.51 | Sell |
200-day SMA: | 20.65 | Sell |
8-day EMA: | 13.66 | Buy |
20-day EMA: | 14.17 | Buy |
50-day EMA: | 15.29 | Sell |
200-day EMA: | 19.19 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 116.25 | Buy |
20-day SMA: | 117.78 | Buy |
50-day SMA: | 122.17 | Buy |
200-day SMA: | 130.04 | Buy |
8-day EMA: | 121.1 | Buy |
20-day EMA: | 119.12 | Buy |
50-day EMA: | 122.54 | Buy |
200-day EMA: | 126.1 | Buy |
Bloomin Brands Earnings Growth & BLMN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.05 per share, and an increase next year of $0.03 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
Bloomin Brands Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |